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Background: 
 Osteoporosis is estimated to affect 200 million women in the world, affecting 
10% of women aged 60, 20% of women aged 70, 40% of women aged 80 and 67% of 
women aged 90. Osteoporosis is characterized by low bone density and increases the risk 
for fractured bones; however, it may be prevented with modifiable factors such as 
supplements, diet, and physical activity. Vitamin D deficiency leads to bone mineral 
density loss, as Vitamin D3 is responsible for calcium absorption into the bones. Bone 
consolidation is believed to occur between 20 and 30 years old; thus, attaining peak bone 
mass is critical during pre-menopause.  
Methods: 
 The relationship between vitamin D and bone mineral density has predominately 
been studied in postmenopausal populations. Therefore, we examined this association 
among 18-30 year old participants (n=271) in the cross-sectional UMass Vitamin D 
Status Study. The modified version of the Harvard Food Frequency Questionnaire was 
used to assess the average intake of vitamin D foods and supplements. Serum 25(OH)D3 
concentrations were assayed from blood samples. Bone mineral content and bone area 
were measured by dual-energy X-ray absorptiometry scan. Bone mineral content (BMC), 
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as measured in grams, provides a measure of bone mass. Bone area (BA), as measured in 
cm2, reflects a two-dimensional area, which is characterized by the periphery of a bone 
region. We used multivariable linear regression to model the relationship between bone 
mineral density and bone area with sources of vitamin D after adjusting for dietary and 
lifestyle factors.  
Results: 
 In the present study, the mean and standard deviation of vitamin D is 372.7 IU 
and 285.8 IU, respectively. For vitamin D from supplements, the mean is 140.9 IU with a 
standard deviation of 232.3 IU. Finally, for vitamin D from food, the mean is 231.8 IU 
with a standard deviation of 182.0 IU. Compared to reference values of 600 IU, these 
data are below the recommended daily allowance. 
 We did not observe an association between total vitamin D or vitamin D from 
foods sources with either BMC or BA. We also did not observe an association between 
serum 25-hydroxyvitamin D levels and BMC or BA.  
Conclusion: 
 Future studies with larger sample sizes are warranted to validate this association 
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 Osteoporosis is estimated to affect 200 million women in the world, affecting 
10% of women aged 60, 20% of women aged 70, 40% of women aged 80 and 67% of 
women aged 90.1 In 2010, there were approximately 9 million cases of osteoporosis 
among American women aged 50 or older. By 2020, this figure is estimated to increase to 
10.5 million cases.2 In 2005, 71% of osteoporosis-related fractures occurred among 
women. Of the total costs of incident fractures, over three-quarters, or $12.8 billion, were 
among women.3 Risk factors for osteoporosis are family history of osteoporosis, age, low 
intake of calcium and vitamin D, physical inactivity, smoking, race, and female sex.4 
Menopause leads to a decrease in estrogen, a hormone that aids in the building of new 
bone.5 Thus, postmenopausal women are at an increased risk of osteoporosis.  
 Osteoporosis is defined as bone mineral density that is 2.5 standard deviations 
below the young adult mean.6 Since bone mineral density decreases gradually with age, 
having a high peak bone mass in young adulthood may prevent or delay osteoporosis 
later in life. Peak bone mass is typically achieved by the age of thirty. Prior to this age, 
modifiable factors such as supplements,7 diet,8 and physical activity/strength training8 
may increase bone mineral density. For example, a study by Alghadir et al. assessed the 
role of physical activity, calcium consumption and lifestyle factors and bone mineral 
density among 350 young adult participants. This study showed that low intake of 
calcium and milk, in addition to higher caffeine and carbonated beverage consumption 
was negatively associated with bone mineral density status.8 Participants were classified 
into groups according to their bone mineral density status. In younger subjects, more than 
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72.6% had normal bone mineral density, while 22.6 and 4.8% had osteopenia and 
osteoporosis, respectively. However, among women aged 25-30, participants showed 
higher proportions of osteopenia (34.9%) and osteoporosis (6.9%). Compared with the 
younger groups of participants, 48.2% of older men and women had normal bone mineral 
density values, while 34.7% and 17.1% had osteopenia and osteoporosis, respectively. 
However, among women aged 31-45, showed the highest prevalence of osteopenia 
(38.5%) and osteoporosis (18.3%).8  
 In a study by Riggs et al, patterns of bone loss were studied among 187 normal 
participants, aged 20-89 years, and in 85 participants with vertebral fractures due to 
osteoporosis. Overall, the predicted mean for bone mineral density at age 90 was 47% 
less than the predicted mean at age 20.9 
 As mentioned previously, while vitamin D is an established risk factor for 
osteoporosis, it is unclear how it is associated in the attainment of peak bone mineral 
density in young adults. For this reason, it is necessary to examine the modifiable factors 
for peak bone density, specifically vitamin D. 
 Vitamin D has two forms; 1) Vitamin D2 (ergocalciferol), 2) Vitamin D3 
(cholecalciferol), and several metabolites.10 Serum 25-hydroxyvitamin D concentrations 
serve as a biomarker for vitamin D.11 Vitamin D3 is produced in two ways: ultraviolet B 
radiation from the sun and diet. Foods such as fatty fish (3 ounces of salmon is equivalent 
to 447 IU of vitamin D), milk (one cup is equivalent to 115-124 IU of vitamin D), egg 
yolk (1 large egg is equivalent to 41 IU of vitamin D), and beef liver (3 ounces is equal to 
42 IU of vitamin D) are sources of vitamin D3.12 It has been suggested by researchers that 
approximately 5-30 minutes of sun exposure without sunscreen between 10 AM and 3 
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PM at least two times a week usually leads to sufficient vitamin D synthesis.13 Vitamin 
D2 is derived solely from plant sources.14 Vitamin D3 assists in bone mineralization and 
activates osteoblasts and osteoclasts. Calcitrol, the hormone derived from vitamin D, 
stimulates the intestines to absorb enough calcium into bone.15 Thus, a vitamin D 
deficiency may lead to loss of bone mineral density.16 Only 10% to 15% of dietary 
calcium and approximately 60% of phosphorus are absorbed into bones as a result of 
vitamin D deficiency.16 Bone loss occurs with excessive osteoid accumulation, as well as 
osteomalacia, or softening of the bones.17 Lack of sunlight exposure (i.e. through use of 
sunscreen or veil) and inadequate dietary vitamin D, as well as malabsorption caused by 
various gastrointestinal (GI) disorders may result in bone mineral loss.17 
 
Physiology of the relationship between vitamin D and bone mineral density 
 The physiological mechanism by which vitamin D impacts bone mineral density 
is stronger in premenopausal women than in postmenopausal women. This is because 
peak rates of calcium accrual occur before the age of 30 years old.18 Previous studies 
have shown that calcium accrual increases during puberty19 and that the highest calcium 
accrual rates occur at a mean age of 12.5 and 14 years old in girls and boys, 
respectively.20 After this rapid calcium accrual period, bone consolidation is believed to 
occur between the ages of 20 and 30 years old,18 further indicating the need for our study. 
 
Epidemiology of the relationship between vitamin D and bone mineral density 
 Only two prior studies investigated the association between vitamin D and bone 
density among premenopausal women.21, 22 One case-control study21 (n=100) and one 
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cross-sectional study22 (n=608) examined the association between serum 25-
hydroxyvitamin D and bone mineral density among 18-30 year old women. One of these 
studies found that vitamin D was positively associated with bone mineral density22 while 
the other resulted in a null association between vitamin D and bone mineral density.21 
One of these studies adjusted for age and body mass index.22 However, neither of these 
studies controlled for important confounding factors such as calcium intake and physical 
activity.21, 22 Calcium and physical activity are positively associated with vitamin D and 
bone mineral density; therefore, not controlling for these factors would lead to an 
overestimate of the association between vitamin D and bone mineral density.31, 32 
 In the only cross-sectional study to assess 25-hydroxyvitamin D levels and bone 
mineral density in healthy premenopausal women, Adami et al. collected serum samples 
of women with regular monthly cyclic menses.22 Evaluation of bone mineral density was 
performed via dual-energy X-ray absorptiometry (DXA) scan at the lumbar spine, the 
femoral neck, and total hip BMD. After adjusting for age and BMI, the regression 
coefficients between 25-hydroxyvitamin D concentrations and spine, femoral neck and 
total hip bone mineral density were +0.084 (p=0.043), +0.013 (non-significant p-value 
>0.1), and +0.021 (non-significant p-value >0.1) respectively.  
 In the only case-control study to assess 25-hydroxyvitamin D levels and bone 
mineral density in patients with fibromyalgia syndrome, Olama et al. collected venous 
blood samples.21 Bone mineral density was measured at the lumbar spine, femoral neck, 
and forearm by DXA. Serum levels of 25-hydroxyvitamin D were inversely correlated 
with BMD at the lumbar spine (p=0.012), however not related to bone mineral density at 
the femoral neck and forearm sites.  
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 In summary, only two studies, to our knowledge, have examined the association 
of vitamin D status and bone mineral density among premenopausal women.21, 22 These 
studies found positive associations between vitamin D status and bone mineral density, 
but did not control for important confounding factors such as calcium intake and physical 
activity. Therefore, we propose to examine the association between dietary vitamin D 
intake and serum levels of 25-hydroxyvitamin D and bone mineral density among 
premenopausal participants (n=271) in the cross-sectional UMass Vitamin D Status 
Study. We hypothesize that among the young women, dietary sources and supplements of 
Vitamin D, and biochemical 25-hydroxyitamin D levels will be positively associated with 































 The UMass Vitamin D Status Study recruited women aged 18-30, who live in 
Amherst and the surrounding area. Women were recruited for this study between 2006 
and 2011 by means of fliers posted around the University campus, by table tents near the 
dining commons, and by classroom announcements.23 
 In a single clinic visit, the study participants completed a modified version of the 
Harvard Food Frequency Questionnaire, as well as a comprehensive lifestyle and activity 
questionnaire.23 The Harvard FFQ was modified from the 1986 version by the following 
ways: zucchini was included in addition to eggplant, green peppers, sauerkraut, and 
avocado were omitted, cole slaw and cabbage were combined into one food item, and 
included beets and prunes. Body mass index (BMI) and blood pressure were directly 
measured. Questions about reproductive health, premenstrual symptoms, attention deficit 
hyperactivity disorder, perceived stress and medication use were collected.23 Before the 
end of the study visit, questionnaires were assessed for completeness and participants 
were asked to clarify any missing, unclear, or incomplete data.24 At the time of their 
clinic visit, each participant provided a fasting blood sample, used to determine vitamin 
D.23  
 Eligible women were aged 18-30 who lived in Amherst or the surrounding area. 
Women were not eligible to participate in this study if they: 1) were pregnant or not 
currently menstruating; 2) had a history of high blood pressure or cholesterol, kidney or 
liver disease, bone disease (i.e. osteomalacia), gastrointestinal disorders, rheumatologic 
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disease, multiple sclerosis, thyroid disease or hyperparathyroidism, cancer, type 1 or 2 
diabetes, or polycystic ovaries; or 3) were currently taking corticosteroids, anabolic 
steroids, anticonvulsants, cimetidine, or propranolol.23  
 We also excluded all participants who did not have complete data on bone 
mineral density and vitamin D status.  
 
Assessment of Vitamin D 
 Vitamin D was measured in two ways. First, a modified version of the Harvard 
Food Frequency questionnaire collected the average intake of 131 foods and supplements 
for the two months prior to the participant’s clinic visit.24 Vitamin D-rich foods included 
in the questionnaire were fortified dairy foods, orange juice, breakfast cereals, dark meat, 
and fish.23 Participants were also asked to specify the brand and the type of multivitamin 
used on the food frequency questionnaire. The Harvard FFQ was analyzed at Harvard 
University. Specifically, the frequency of intake of each food item was multiplied by its 
vitamin D content, and then summed across all items of food. Contributions from vitamin 
D supplemental sources were added to contributions from dietary vitamin D to calculate 
total vitamin D intake.25 Intake of vitamin D foods and supplements from the FFQ were 
examined continuously (Table 2). 
The Harvard Food Frequency Questionnaire was previously validated by Willett 
et al.26, 27 Four one-week dietary records and two food frequency questionnaires were 
completed over one year by 173 participants. The mean correlation coefficients 
comparing the dietary records and first and second food frequency questionnaires were 
0.44 and 0.52, respectively. The correlation coefficients of the FFQ were high and 
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reproducible indicating that a single FFQ is valid and reproducible for assessing specific 
food and beverage intake.26, 27 
 The second technique for measuring vitamin D status was via fasting blood 
samples, which were used to measure serum 25-hydroxyvitamin D3 concentrations. 
Blood samples were processed and stored generally within two hours at -80 degrees 
Celsius.28 Serum 25(OH)D3 concentrations were determined using DiaSorin’s 
commercially available radioimmunoassay kit.28 Total serum 25-hydroxyvitaminD levels 
were examined continuously (Table 2). 
 The radioimmunoassay available by DiaSorin used to measure serum 25-
hydroxyvitamin D3 concentrations has been previously validated by Hollis, as well as the 
UMass Vitamin D Status Study research team.28 Both within- and between-assay 
coefficient of variations were low (0.2-5.8%).28 
 The new recommended daily allowance is 600 IU for those aged 18-30. Thus, in 
the present study, Vitamin D was also categorized into intake less than 600 IU per day 
and intake greater than or equal to 600 IU per day for additional analyses (Table 7). 
Vitamin D deficiency is defined as a 25-hydroxyvitamin D level less than 50 nmol/L for 
those aged 18-30. In the present study, Vitamin D was also categorized into serum 25-
hydroxyvitamin D levels less than 50 nmol/L and levels greater than or equal to 50 
nmol/L (Table 7).  
 
Assessment of Bone mineral density 
 Bone mineral content (BMC) and bone area (BA) were directly measured using 
what is considered the gold standard, dual-energy X-ray absorptiometry (DXA). The in 
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vivo precision of the specific DXA machine used, the GE Lunar Prodigy scanner, ranges 
from 1.0-2.2% for bone mineral content.24 Bone mineral content, as measured in grams, 
provides a measure of bone mass. Bone area, as measured in cm2, reflects a two-
dimensional area, which is characterized by the periphery of a bone region.  
 For the UMass Vitamin D Status study, bone mineral content and bone area was 
measured during the participant’s clinic visit using DXA scan. The total body scan mode 
was used on a narrow angle fan GE Lunar Prodigy Scanner (GE Lunar Corp., Madison, 
WI, USA).29 Provided by the manufacturer, daily calibrations were performed using the 
standard calibration phantom.24 With the exception of 31 participants, all DXA scans 
were performed on the morning of the participant’s clinic visit.24 All DXA scans were 
analyzed by a single examiner.24   
 
Covariate Assessment 
 Information on lifestyle and demographics were collected by self-reported 
questionnaire at the time of the clinic visit. Questions included smoking status and 
number of cigarettes per day, and use of oral contraceptives and selective serotonin 
reuptake inhibitors (Table 1).23 These variables were analyzed categorically (Table 1). 
Questions regarding physical activity were based on those previously used and validated 
in the Nurses Health Study II.30 Women were asked to report the time per week that they 
were engaged in specific physical activities such as, walking, jogging, running, 
aerobics/dancing, tennis/racket sports, swimming, yoga or Pilates, and weight training.23 
Total MET-hours (i.e. Metabolic Equivalent of Task) per week was calculated for each 
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specific activity.23 Physical activity in MET-hours per week was analyzed continuously 
(Table 1).   
 Each study participant’s weight and height were directly measured and used to 
calculate BMI by the following formula: weight (kg)/height (m2).23 A modified version of 
the Harvard Food Frequency Questionnaire (FFQ) was used to collect data on participant 
total caloric intake, as well as dietary intake of calcium. Sun exposure was determined by 
self-reported time spent outdoors wearing minimal clothing, use of tanning beds, use of 
sunscreen, and recent travel to sunny locations.23 The variables BMI and sun exposure 
were analyzed categorically, and the variables for daily intake of calories and calcium 
were analyzed continuously (Table 1).  
 
Statistical Analysis 
 We present the distribution of vitamin D intake from dietary and supplement data 
as well as serum 25-hydroxyvitamin D levels (Table 2) and the distribution of bone 
mineral content and bone area (Table 3). 
 Covariate distributions were assessed against total vitamin D intake and 25(OH)D (Table 
4) and against bone mineral content and bone area (Table 5). Categorical covariate 
variables were assessed using t-tests or analysis of variance, as appropriate. Means, 
standard deviations and p-values are reported. Continuous covariate variables were 
assessed using unadjusted linear regression, modeled as the exposure/outcome as the 
dependent variable and the covariate as the independent variable. Beta coefficients, 
standard errors, and p-values are reported. 
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Unadjusted linear regression models the association between vitamin D status and 
bone mineral density. We report beta coefficients, standard errors and p-values (Table 6). 
We used multivariable linear regression to examine the association between vitamin D 
and bone mineral content and bone area (Table 6). Covariates were assessed for 
confounding through individual inclusion into the age-adjusted model of vitamin D status 
and bone mineral content and bone area. We performed the change in estimate procedure, 
and covariates that resulted in a 10% change in any of the bone mineral density status 
were considered confounders in the final model. Physical activity in METs, calcium 
intake, BMI, total caloric intake were included in the final model due to their recognized 
associations with vitamin D and bone mineral density in the current literature.31-34 The 
covariates that resulted in a 10% change in either bone mineral content or bone area and 
were considered confounders in the final model were age, ever smoke, and daily intakes 
of calcium and protein. Thus, we retained variables age, body mass index, ever smoke, 
physical activity in METs, caloric intake, calcium intake, and protein intake in our final 
multivariable models. After adjustment, vitamin D measures were not associated with 
bone mineral content. All analyses were performed using statistical software STATA 









 Of the 298 participants, 290 had complete dietary vitamin D data as recorded 
from the FFQ, 284 had serum 25(OH)D levels available, and 279 had complete bone 
outcome data; thus, 271 were included in the present analysis as they had complete data 
for our exposure and outcomes, as well as complete data recorded of our covariates. The 
average age of study participants was 21.4 years old. The majority, 86% of the study 
participants were white. As portrayed in Table 1, 79% of study participants were of 
underweight or normal BMI, with the remaining 21% overweight, obese category I or II.  
 Mean vitamin D intake and bone measures in the population are presented in 
tables 2 and 3. The total mean for participant self-reported vitamin D IU was 372.7 
(standard deviation 285.8). Self-reported vitamin D IU for participants who took vitamin 
D supplement was mean value of 140.9 (standard deviation 232.3), and for participants’ 
vitamin D from food was mean value of 231.8 (standard deviation of 182.0). Serum 25-
hydroxyvitamin D levels measured in nmol/L mean value for participants was 88.0 
(standard deviation of 36.7).  
 Among the 271 participants, the distribution of bone mineral density status is as 
follows. We observed a mean of 2547.6 g (standard deviation of 347.0 g) for bone 
mineral content, and a mean of 2190.7 cm2 (standard deviation of 207.7 cm2), as 
measured by dual energy X-ray absorptiometry.  
 
 Calories (kcal) (P<0.001), total fat (gm) (P=0.006), iron (mg) (P<0.001), total 
calcium intake (mg) (P<0.001), protein (gm) (P<0.001), and vitamin A (IU) (P<0.001) 
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measures were positively associated with total vitamin D intake (IU); however, these 
were not associated with serum 25(OH)D (nmol/L). In analysis of variance, BMI (kg/m2) 
was associated with both bone mineral content (g) (P<0.001) and bone area (cm2) 
(P<0.001). Physical activity, in MET (hours/week) was positively associated with bone 
mineral content (g) (P=0.05), but not bone area. All other covariate distributions, 
presented in table 4 and 5, were not statistically significant. 
 
Total Vitamin D intake 
 Vitamin D intake was not associated with BMC or BA. For example, each 100 
IU/day increase in total vitamin D was associated with a 4.7 g lower BMC (P = 0.55) 
Similarly, each 100 IU/day increase in total vitamin D was associated with a 0.01 cm2 
lower BA (P=0.83).  
 
Total Vitamin D from food sources 
 Each 100 IU/day increase in vitamin D from food sources was associated with a 
17.8 g lower BMC (P = 0.23). Each 100 IU/day increase of vitamin D from foods was 
associated with a 0.08 cm2 lower BA (P=0.41). 
 
Serum 25-hydroxyvitamin D 
 Each 10 nmol/L increase in 25(OH)D was associated with a 5.9 g higher BMC 
(P=0.25).  Similarly null, each 10 nmol/L increase in 25(OH)D was associated with a 
0.03 cm2 higher BA (P=0.36).  
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Recommended levels of Vitamin D 
 The new recommended daily allowance is 600 IU for those aged 18-30. Thus, in 
the present study, Vitamin D was categorized into intake less than 600 IU per day and 
intake greater than or equal to 600 IU per day. The number of participants whose vitamin 
D intake that was greater than or equal to the recommended allowance of 600 IU per day 
was 45 (16.6%). A great majority of the study participants (n=226, 83.4%) had vitamin D 
intake that was less than the recommended allowance of 600 IU/day. 
 In unadjusted models, the difference between those whose vitamin D intake was 
less than the recommended allowance of 600 IU per day and those whose vitamin D 
intake was greater than or equal to the recommended allowance of 600 IU per day is 30.3 
g higher BMC (P = 0.59). The difference between those whose vitamin D intake was less 
than the recommended allowance of 600 IU per day and those whose vitamin D intake 
was greater than or equal to the recommended allowance of 600 IU per day is 0.14 cm2 
higher BA (P = 0.68).  
 After adjustment, the difference between those whose vitamin D intake was less 
than the recommended allowance of 600 IU per day and those whose vitamin D intake 
was greater than or equal to the recommended allowance of 600 IU per day is 46.6 g 
lower BMC (P = 0.41). The difference between those whose vitamin D intake were less 
than the recommended allowance of 600 IU per day and those whose vitamin D intake 
was greater than or equal to the recommended allowance of 600 IU per day is 0.24 cm2 
lower BA (P=0.50).  
 
Recommended levels of 25-hydroxyvitamin D 
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 Vitamin D deficiency is defined as a 25-hydroxyvitamin D level less than 50 
nmol/L for those aged 18-30. In the present study, Vitamin D was categorized into serum 
25-hydroxyvitamin D levels less than 50 nmol/L and levels greater than or equal to 50 
nmol/L.  
 In unadjusted models, the difference between those whose 25-hydroxyvitamin D 
levels less than 50 nmol/L and those whose 25-hydroxyvitamin D levels were greater 
than or equal to 50 nmol/L is 110.7 g higher BMC (P = 0.095). The difference between 
those whose 25-hydroxyvitamin D levels less than 50 nmol/L and those whose 25-
hydroxyvitamin D levels were greater than or equal to 50 nmol/L is 0.73 cm2 higher BA 
(P = 0.06).  
 After adjustment, the difference between those whose 25-hydroxyvitamin D 
levels less than 50 nmol/L and those whose 25-hydroxyvitamin D levels were greater 
than or equal to 50 nmol/L is 48.3 g higher BMC (P=0.42). The difference between those 
whose 25-hydroxyvitamin D levels less than 50 nmol/L and those whose 25-
hydroxyvitamin D levels were greater than or equal to 50 nmol/L is 0.42 cm2 higher BA 











Epidemiology of the relationship between vitamin D and bone mineral density 
 We found a null association between total vitamin D, vitamin D from foods, and 
serum 25-hydroxyvitamin D and both BMC and BA. Our results are somewhat consistent 
with previous findings of two prior studies that investigated the association between 
vitamin D and bone density among premenopausal women.21, 22 The case-control study21 
found a null association, while the cross-sectional study22 that examined the association 
between serum 25-hydroxyvitamin D and bone mineral density among premenopausal 
women found that vitamin D was positively associated with bone mineral density. Even 
though one of these studies adjusted for age and body mass index,22 neither of these 
studies controlled for important confounding factors such as calcium intake and physical 
activity.21, 22  Further, we examined the relationship between vitamin D and BMC and BA 
also adjusting for ever smoke, caloric intake and protein intake. This could be the 
reasoning why our results are not consistent with the aforementioned studies. The 
relationship between Vitamin D and BMC and BA may have been different in the other 
two studies if they had collected data on these important confounding factors, calcium 
intake, physical activity, ever smoke, caloric intake and protein intake.  
 The two studies were similar in both exposure and outcome assessment. In the 
cross-sectional study, Adami et al. collected serum samples of healthy premenopausal 
women with regular monthly cyclic menses.22 Evaluation of bone mineral density was 
performed via dual-energy X-ray absorptiometry (DXA) scan at the lumbar spine and the 
femoral neck. In the case-control study, Olama et al. collected venous blood samples of 
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25-hydroxivitamin D in patients with fibromyalgia syndrome.21 Bone mineral density 
was measured at the lumbar spine, femoral neck, and forearm by DXA. Thus, both 
studies were similar in exposure and slightly similar in outcome assessment. These 
previous studies looked at bone mineral density in specific regions, while ours looked at 
total body BMC and BA, which could further explain the different findings. 
 For the unadjusted results in the study conducted by Adami et al, the relationship 
between the logarithmic values of 25-hydroxyvitamin D concentrations and spine BMD, 
femoral neck BMD and total hip BMD is +0.025 (non-significant p-value >0.1), -0.074 
(P=0.034), and -0.047 (non-significant p-value >0.1), respectively. In the study 
conducted by Olama et al., after adjustment, serum levels of 25-hydroxyvitamin D were 
inversely correlated with BMD at lumbar spine (p = 0.012), and null for femoral neck and 
forearm locations.  
 In the only cross-sectional study to assess 25-hydroxyvitamin D levels and bone 
mineral density in healthy premenopausal women, Adami et al., after adjustment for age 
and BMI, the regression coefficients between 25-hydroxyvitamin D concentrations and 
spine and femoral neck bone mineral density were +0.084 grams per centimeter squared 
(p=0.043) and +0.013 grams per centimeter squared  (non-significant p-value), 
respectively.22 Similar to the previous literature, this study did not measure self-reported 
dietary vitamin D values from a food frequency questionnaire.  
 Our study is not similar to these findings, in that Adami et al. found a positive 
association between serum 25-hydroxyvitamin D and both BMC and BA, while our 
results were null.  The outcomes were different across studies in comparison to our study 
methods. Olama et al found a null association with a sample size of 100, whose null 
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results may be due to the sample size. While Adami et al found a positive association 
with a sample size of 608. Both of these studies had bone mineral density, measured in 
grams per centimeter squared as an outcome. Contrastingly, the present study used bone 
mineral content, measured in grams, and bone area, measured in centimeters squared. As 
we did not evaluate bone mineral density, but rather bone mineral content and bone area, 
this could explain the different findings of our null results from the current literature.  
 In the cross-sectional study conducted by Adami et al., the level of 25-
hydroxyvitamin D where an association between serum 25-hydroxyvitamin D and bone 
mineral density was detectable was 20 ng/ml. In comparing this to the present study, this 
value is equivalent to 50 nmol/L. Our mean for 25-hydroxyvitamin D concentrations was 
88.0 nmol/L, with a standard deviation of 36.7 nmol/L. Given these values, our study 
does not have enough power to detect an association between serum 25-hydroxyvitamin 
D concentrations at the low end of the range and bone density.  
 
Non-differential misclassification of vitamin D 
 The Harvard Food Frequency Questionnaire was previously validated by Willett 
et al., indicating that a single FFQ is valid and reproducible for assessing micronutrient 
intake.26 Vitamin D intake was calculated using a modified version of the Harvard Food 
Frequency questionnaire. However, it is possible that women incorrectly reported their 
intake of vitamin D-rich foods, due to a misunderstanding of what constitutes a single 
serving of food. To the extent that non-differential misclassification occurs, our observed 
association for the continuous assessment of vitamin D intake would be an underestimate 
of the true association, causing a bias toward the null. In the present study, the 
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relationship between total vitamin D and vitamin D from foods and bone mineral density 
and bone area suggest a null relationship. Therefore, non-differential misclassification of 
vitamin D on the food frequency questionnaire is possible. Further, non-differential 
misclassification of nutrients is common in nutritional epidemiological studies. 
Vitamin D status was measured using fasting blood samples of serum 25-
hydroxyvitamin D3 concentrations. Any potential misclassification of exposure is due to 
lab measurement error and the resulting non-differential misclassification of serum 25-
hydroxyvitamin D3 concentrations would underestimate the true association and result in 
a bias toward the null. However, this is unlikely because the radioimmunoassay used to 
measure serum 25-hydroxyvitamin D3 concentrations has been previously validated by 
UMass Vitamin D Status Study research team, and both within- and between-assay 
coefficient of variations were low (0.2-5.8%).28   
 
Non-differential misclassification of bone mineral density 
 Bone mineral content and bone area were measured with the DXA scan. If the 
measurements of bone mineral content and bone area were incorrectly measured, then the 
observed association would be an underestimate of the true association. Bone mineral 
content and bone area was measured with what is widely accepted as the standard. 
Furthermore, the in vivo precision indicates that this method is valid and reproducible for 
assessing this outcome.28 Therefore, we expect misclassification of outcome to be 
unlikely and the impact to be minor.  
 The range of the bone measures in the present study is as follows: for bone 
mineral content is 1833-3682 grams, and for bone area is 1684-2709 centimeters squared. 
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In the only study that had a positive association between serum 25-hydroxyvitamin D 
values and bone mineral density,22 the range of bone mineral density at the spine, femoral 
neck, and total hip is: 1.051 ± 0.122 grams per centimeter squared, 0.919 ± 0.119 grams 
per centimeter squared, and 0.804±0.124 grams per centimeter squared, respectively. Our 
study outcomes are comparable to the study conducted by Adami et al. As determined by 
the range of bone mineral content and bone area, there was a wide enough range to allow 
us to see a relationship between serum 25-hydroxyvitamin D and bone mineral content 
and area.  
 
Selection Bias 
 The present study is cross-sectional, and as such information is collected on 
exposure and outcome at the same time at baseline. Differential selection of participants 
into the study based on their exposure and outcome could occur if people who were both 
vitamin D deficient and had low bone mineral density were more motivated to participate. 
This would cause an increase in the “a” cell, and an over-estimate of the true association. 
However, selection bias is unlikely because women who participated were unaware of 
their bone mineral density and vitamin D status. 
 
Information Bias 
 Information bias occurs when information on disease outcome is collected in a 
differential way between exposed and non-exposed groups. In this cross-sectional study, 
information bias could occur if those with low bone mineral density were more motivated 
to recall vitamin D intake than those with normal bone mineral density. As a result of this 
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recall bias, we would see an overestimate of the frequency of exposure among those with 
low bone mineral density, and a bias away from the null. Reducing this concern are 
several facts. First, the Harvard Food Frequency Questionnaire used for this study to 
collect vitamin D intake was previously validated by Willett et al. with high validity.26 
Second, the women enrolled into the study did not know their bone mineral density at the 
time of their clinic visit. Third, the food frequency questionnaire collected a wide variety 
of information such as calcium, alcohol and other nutrients; thus, the participants were 
unaware of hypothesis at the time of their visit. Therefore, we believe that recall bias in 
this study is unlikely and the impact would be minor. 
 
Confounding 
Confounders are other risk factors for the outcome of interest (i.e. low bone 
mineral density) and are also associated with the exposure of interest. However, it is 
likely that residual confounding will remain after creation of the final model because not 
all covariates are perfectly measured. In addition, we do not have participant information 
on diseases such as the autoimmune disease, systemic lupus erythematosus. Women who 
have systemic lupus erythematosus may spend less time in the sun, and thus receive less 
vitamin D. As such, if systemic lupus erythematosus was negatively associated with both 
vitamin D status35 and bone mineral density,36 we would observe an overestimate of the 
true association. However, lupus is an uncommon disease, and therefore we would not 
expect this to be a confounder. 
In our study, we analyzed characteristics other than vitamin D intake of the 
exposed group that could have led to their developing low bone mineral density. We 
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collected information on potential confounders, including physical activity (measured as 
total MET-hrs/week), sun exposure, calcium intake, total caloric intake, selective 
serotonin reuptake inhibitor use, and oral contraceptive use. To reduce confounding of 
the association between vitamin D and bone mineral density by these variables, we used 
multivariable linear regression.  
 
Temporal Bias 
 Cross-sectional studies are subject to temporal bias, an inability to determine 
whether the exposure preceded the outcome. If bone mineral density influences exposure 
status (i.e. vitamin D), then we cannot conclude that the intake of vitamin D intake 
preceded the status of bone mineral density. We would therefore conclude that the 
observed association incorrectly describes the association between vitamin D intake and 
bone mineral density. However, it is unlikely that bone mineral density influences the 
status of vitamin D because the proposed physiological mechanism of this association is 
that vitamin D3 assists in bone mineralization. Therefore, since vitamin D3 is responsible 
for the absorption of calcium into bone from the small intestine, the threat of temporal 
bias is minimized. 
 
Generalizability 
 One of the proposed physiological pathways for the association between vitamin 
D intake and bone mineral density is that Vitamin D3 assists in bone mineralization, as it 
is involved in the activation of osteoblasts and osteoclasts. Vitamin D3 is responsible for 
the absorption of calcium into bone from the small intestine. There is no evidence to 
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suggest this association would be different among other women not included in the study, 
therefore the results should be generalizable to most people. If the physiological 
mechanism for the association between vitamin D intake and bone mineral density is 
























 In our study, vitamin D was not associated bone mineral density outcomes. Our 
results indicated a null association between vitamin D and BMC and BA, a null 
association between vitamin D from foods and BMC and BA, and a null association 
between serum 25-hydroxyvitamin D and BMC and BA. The previous study conducted, 
which found a positive relationship between serum 25-hydroxyvitamin D and bone 
mineral density, was substantially larger.17 Further studies with larger sample sizes as 
well as with daily FFQ recordings, are warranted to make a public health 
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